BED BATH & BEYOND INC. REPORTS THIRD QUARTER RESULTS (ENDING NOVEMBER 27, 2021) DELIVERING STRONG GROSS MARGIN PERFORMANCE
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Wall St slides as oil hovers near $100 on rising Middle East tensions
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Oil nears $100 as fresh Middle East strikes raise supply risks
- How big a risk are rates to the AI boom?
- 3 reasons why S&P 500 may drop up to 10% in the near term: RBC
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Bed Bath & Beyond (BBBY) PT Lowered to $9.50 at BofA Securities
January 7, 2022 9:23 AM ESTBofA Securities analyst Jason Haas lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $9.50 (from $11.50) while maintaining a Underperform rating.
... MoreBed Bath & Beyond (BBBY) PT Lowered to $15 at Goldman Sachs
January 7, 2022 6:13 AM ESTGoldman Sachs analyst Kate McShane lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $15.00 (from $20.00) while maintaining a Sell rating following results as comps seen as remaining lackluster due to traffic challenges and supply chain woes.
... MoreBed Bath & Beyond (BBBY) Earses Earlier Decline, Now Up 10% Following Results and Guidance
January 6, 2022 8:22 AM ESTBed Bath & Beyond (NASDAQ: BBBY) Earses Earlier Decline, Now Up 10% Following Results and Guidance
... MoreBed Bath & Beyond (BBBY) Misses Q3 EPS by 25c, Q4 Guidances Falls Short of Consensus
January 6, 2022 7:32 AM ESTBed Bath & Beyond (NASDAQ: BBBY) reported Q3 EPS of ($0.25), $0.25 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $1.88 billion versus the consensus estimate of $1.96 billion.
GUIDANCE:
Bed Bath & Beyond sees Q4 2021 EPS of $0.00-$0.15, versus the consensus of $0.72. Bed Bath & Beyond sees Q4 2021 revenue of $2.1 billion, versus the consensus of $2.27 billion.
As a reminder, Net Sales throughout fiscal 2021... More